XML 37 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
STOCK-BASED COMPENSATION
6 Months Ended
Jun. 30, 2018
Disclosure Of Compensation Related Costs Sharebased Payments [Abstract]  
STOCK-BASED COMPENSATION

12. STOCK-BASED COMPENSATION

The following table summarizes the Company’s stock awards granted for each of the periods indicated:

 

 

 

For the Three Months Ended June 30,

 

 

For the Six Months Ended June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

 

Grants

 

 

Weighted

Average

Grant

Date Fair

Value

 

Stock options

 

 

528,096

 

 

$

45.45

 

 

 

3,579,467

 

 

$

13.64

 

 

 

1,652,681

 

 

$

37.71

 

 

 

4,456,959

 

 

$

14.16

 

Restricted stock units

 

 

18,695

 

 

$

95.38

 

 

 

20,000

 

 

$

36.26

 

 

 

169,420

 

 

$

74.09

 

 

 

181,029

 

 

$

33.03

 

Restricted stock awards

 

 

 

 

$

 

 

 

335,000

 

 

$

34.65

 

 

 

17,090

 

 

$

71.45

 

 

 

341,500

 

 

$

34.58

 

 

Stock-based Compensation Expense

For the three months ended June 30, 2018 and 2017, total stock-based compensation expense was $15.3 million and $10.5 million, respectively. For the six months ended June 30, 2018 and 2017, total stock-based compensation expense was $25.8 million and $16.2 million, respectively. The increase in stock-based compensation expense for both the three and the six months was partially driven by the achievement of a milestone related to the September 2016 restricted stock awards with performance conditions. The following table summarizes stock-based compensation expense by function included within the unaudited condensed consolidated statements of operations and comprehensive loss: 

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Research and development

 

$

5,029

 

 

$

2,195

 

 

$

7,089

 

 

$

4,069

 

Selling, general and administrative

 

 

10,250

 

 

 

8,270

 

 

 

18,716

 

 

 

12,108

 

Total stock-based compensation expense

 

$

15,279

 

 

$

10,465

 

 

$

25,805

 

 

$

16,177

 

 

The following table summarizes stock-based compensation expense by grant type included within the unaudited condensed consolidated statements of operations and comprehensive loss:

 

 

 

For the Three Months Ended

June 30,

 

 

For the Six Months Ended

June 30,

 

 

 

2018

 

 

2017

 

 

2018

 

 

2017

 

 

 

(in thousands)

 

Stock options

 

$

9,382

 

 

$

6,763

 

 

$

18,355

 

 

$

11,801

 

Restricted stock awards/units

 

 

5,407

 

 

 

3,250

 

 

 

6,667

 

 

 

3,454

 

Employee stock purchase plan

 

 

490

 

 

 

452

 

 

 

783

 

 

 

922

 

Total stock-based compensation expense

 

$

15,279

 

 

$

10,465

 

 

$

25,805

 

 

$

16,177